Health News

VENLO, Netherlands & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary third-quarter 2026 financial results. Net sales were $548 million at both reported and constant exchange rates (CER). Adjusted diluted earnings per share (EPS) were $0.65, also $0.65 CER. QIAGEN plans to report full Q3 2026 results on Wednesday, November 4, 2026, at approximately 22:05 Frankfurt time / 16:05 New York time. Given the announced transaction wit...

VENLO, Netherlands & AMSTERDAM--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (“QIAGEN” or the “Company”) and the EQT XI fund (“EQT Private Equity”) today announced an agreement under which Crown NL Bidco B.V. (the “Bidder”) announced its decision to make an all-cash voluntary public takeover offer for the acquisition of all outstanding QIAGEN shares at €46.50 per share (the “Takeover Offer”). The Bidder is a holding company indirectly controlled by EQT XI fund with f...

GREEN BAY, Wis.--(BUSINESS WIRE)--Healthcare environments are being asked to support increasingly complex needs as care delivery models, technology, workforce expectations, and patient expectations continue to evolve. At Healthcare Design Conference + Expo 2026, conversations with healthcare architects, interior designers, and industry leaders reinforced several considerations that KI, KI Wall, and Pallas Textiles brought to the show: the importance of movement, the need for adaptable environme...

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its third quarter 2026 financial results before the market opens on October 30, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its financial results. The press release will be available on the company’s website at investors.kenvue.com. About Kenvue Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a ce...

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release third quarter 2026 financial results after market close on Thursday, November 5, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE: RCUS), a late clinical-stage biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer and immune diseases, today announced that it has commenced an underwritten public offering of its common stock. All of the shares of common stock are being offered by Arcus Biosciences. In addition, Arcus Biosciences intends to grant the underwriters a 30-day option to purchase...

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Gaurav Khanna as chief digital & information officer. In this role, Khanna will lead Ardent's technology, data, AI and digital strategy to support patient care, operational excellence and long-term growth. “We're committed to building the capabilities that will help Ardent continue to deliver exceptional ca...

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third quarter 2026 GAAP income per diluted share of $0.73 and adjusted income per diluted share of $0.89. Financial results are summarized below:   Three months ended   Nine months ended   September 30,   September 30,   2026   2025   2026   2025                 (In millions, except per-share results) Premium Revenue $10,457   $10,841   $30,873   $32,337 Total Revenue $11,082   $11,477   $32,...

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Results Revenue for the three months ended September 30, 2026 increased 8.5% to $716.0 million, compared to $659.9 million for the comparable prior-year period. On a constant currency basis, revenue for the third quarter of 2026 increased 8.6% compared to the third quarter of 2025. Backlog as of September 30...

TRUMBULL, Conn.--(BUSINESS WIRE)--CooperSurgical announces the donation of more than 300 cord blood samples and additional funding to support ongoing stem cell research...